Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

CVS Health Corp. buy Wells Fargo & Company

Start price
€51.46
18.11.24 / 50%
Target price
€62.44
18.11.25
Performance (%)
30.28%
End price
€67.04
19.11.25
Summary
This prediction ended on 19.11.25 with a price of €67.04. The BUY prediction by Wells_Fargo___Compan for CVS Health Corp. saw massive gains of 30.28%. Wells_Fargo___Compan has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €0.64 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this prediction

CVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.

Performance without dividends (%)
Name 1w 1m 1y
CVS Health Corp. -6.236% -6.236% 24.116%
iShares Core DAX® 0.760% 1.149% 17.258%
iShares Nasdaq 100 0.732% 1.884% 8.152%
iShares Nikkei 225® 1.025% -0.865% 13.066%
iShares S&P 500 -0.036% 1.480% 3.393%

Comments by Wells_Fargo___Compan for this prediction

In the thread CVS Health Corp. diskutieren
Prediction Buy
Perf. (%) 30.28%
Target price 62.436
Change
Ends at 18.11.25

CVS Health Co. (NYSE: CVS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $66.00 price target on the stock, up previously from $60.00.
Ratings data for CVS provided by MarketBeat

In the thread Trading CVS Health Corp.
Prediction Buy
Perf. (%) 30.28%
Target price 62.436
Change
Ends at 18.11.25

Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten

Current prediction by Wells_Fargo___Compan for CVS Health Corp.

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€62.74
13.02.25
€69.99
13.02.26
3.32%
10:59

Stopped prediction by Wells_Fargo___Compan for CVS Health Corp.

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€67.91
13.11.25
€88.02
13.11.26
-4.55%
10:59

buy
CVS Health Corp.

Start price
Target price
Perf. (%)
€59.00
06.05.25
-
06.05.26
9.86%
10:59